Ribosome biogenesis is controlled by various major proto-oncogenes and tumour suppressors, such as c-Myc, p53, and the retinoblastoma protein Rb, which deregulate ribosome biogenesis to meet the increased demand of protein synthesis in cancer cells [112,113]. The gene discussed is MYC; the disease is neoplasm.